A groundbreaking one-time gene therapy has the potential to liberate individuals suffering from α-thalassemia, a rare and debilitating blood disorder, from the necessity of lifelong blood transfusions. Image by kjpargeter…

Subscribe Now for Real-time Updates on the Latest Stories!
The field of pharmaceuticals is currently experiencing a significant transformation, akin to the disruptive impact of AI on Silicon Valley,…
Responding to the crisis The consequences of these substandard drugs are clear: ineffective treatment, potential harm to patients, and a…
The caregiving industry is facing a pivotal moment as the U.S. population rapidly ages, with the number of individuals over…
ADHD medication has long been a topic of debate and discussion, with concerns about its effectiveness and potential side effects.…
In the late 1970s, individuals with serious mental illness (SMI) were often overlooked in America's workforce agenda. They were perceived…
The Advisory Committee on Immunization Practices (ACIP) has announced a new review of long-approved vaccines and the cumulative effect of…
A recent study conducted by the University of Florida Health has shed light on the limitations of using body mass…
This week in the world of healthcare innovation, there are several exciting developments to keep an eye on. From efforts…
Sign in to your account